Open AccessRitonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?
Author(s) -
Indy G Murdoch,
Tom Jacobs,
Rosa M Nieuwenhuize,
Quirine C. van Rossum-Schornagel,
Carolina A. M. Schurink,
Nielka P. van Erp,
David M. Burger
Publication year - 2022
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003115
Subject(s) - ritonavir , medicine , docetaxel , abacavir , paclitaxel , taxane , oncology , pharmacology , metastatic breast cancer , darunavir , cart , cobicistat , cancer , gastroenterology , breast cancer , viral load , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , mechanical engineering , engineering